88IV - PR Newswire Asia's news


Immunofoco Biotech to Unveil Solid Tumor CAR-T Programs Clinical Trial Data at 2024 ASCO Meeting CHICAGO , June 2, 2024 /PRNewswire/ -- On June 1 st , 2024, Immunofoco Biotech, a company dedicated to developing cell therapy products for solid tumors, announced that the clinical research data for ... 2024-06-02T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Z Grills Announces Unprecedented "Buy 1, Get 10 Grills" Promotion, Unlocking a Lifetime of Easier Grilling! ONTARIO, Calif. , June 1, 2024 /PRNewswire/ -- Mark your calendars, grill masters! Z Grills, the innovator in premium wood pellet grills, is sizzling up summer with a groundbreaking promotion that's ... 2024-06-01T Food/Beverages Household/Consumer/Cosmetics Retail
Tag along with Jason in Zhengzhou: Experiencing Kung Fu at the Shaolin Temple BEIJING , May 30, 2024 /PRNewswire/ -- This is a report from China.org.cn about the Shaolin Temple: ... 2024-06-01T
Immunocan Launches Innovative Alpaca-derived Nanobody Discovery Platform: ImmuAlpaca® Mouse BOSTON , June 1, 2024 /PRNewswire/ -- Immunocan announces significant progress in the construction of its alpaca-derived nanobody discovery platform, ImmuAlpaca ® mouse. The IGH-VDJ genes in ... 2024-06-01T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
TiumBio Presents Phase 1b Interim Results for TU2218 in Combination with Pembrolizumab at ASCO 2024 Annual Meeting Poster presentation features the interim data from an ongoing Phase 1b clinical trial of TU2218 plus Keytruda combination therapy in patients with advanced solid tumors A 40% overall response ... 2024-06-01T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Chemotherapy Separate & Distinct from HARMONi-2 Announcement, HARMONi-A Showed Clinically Meaningful and Statistically Significant Benefit: PFS Hazard Ratio of 0.46 ... 2024-06-01T Health Care/Hospital Medical/Pharmaceuticals
Duke-NUS' largest graduating cohort celebrates diverse pathways to medicine The largest graduating class in Duke-NUS' history saw 90 graduates, including the first-ever Master of International Translational Medicine cohort, receive their degrees Collectively, this cohort ... 2024-06-01T Education Health Care/Hospital Higher Education
ZEEKR Announces May 2024 Delivery Update HANGZHOU, China , June 1, 2024 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("ZEEKR" or the "Company") (NYSE: ZK), a fast-growing intelligent battery electric vehicle ... 2024-06-01T Auto Transportation
BLUETTI EP760 Achieves CEC Approval, Enhancing Its Appeal in Australia SYDNEY , June 1, 2024 /PRNewswire/ -- BLUETTI , a pioneer in clean energy storage solutions, has achieved a s ignificant milestone in the Australian market. The Clean Energy Council (CEC) has added ... 2024-06-01T Alternative Energies Environmental Products & Services Green Technology
Gold Pecker Leads the Way: First Expert Advisor to Offer 'PAMM by Gold Pecker' for Gold Traders Empowering Gold Investors with Professional Management and Strategic Profit Opportunities ... 2024-06-01T Banking/Financial Service Computer/Electronics